Pfizer Inc. (NYSE:PFE) to Post Q1 2023 Earnings of $0.72 Per Share, Jefferies Financial Group Forecasts

Jefferies Financial Group lowered their Q1 2023 earnings estimates for shares of Pfizer in a note issued to investors on Friday, March 17th. Jefferies Financial Group analyst A. Tewari now anticipates that the biopharmaceutical company will post earnings per share of $0.72 for the quarter, down from their previous estimate of $0.78. Jefferies Financial Group … Read more

Pfizer (NYSE:PFE) reported Q4 2022 Revenues of $24.3 Billion,update 2023 financial guidance

January 31, 2023 — Pfizer Inc. (NYSE:PFE) reported exceptional financial results for fourth-quarter and full-year 2022 and provided 2023 financial guidance. Pfizer Inc. (NYSE:PFE) reported Q4 adjusted earnings  of $1.14 per diluted share, up from $0.79 a year earlier. Analysts polled by Capital IQ expected $1.04. Revenue for the quarter was $24.29 billion, up from … Read more

Pfizer (NYSE:PFE) to acquire Seagen (NASDAQ:SGEN) for $43 billion

Pfizer Inc (NYSE:PFE) said Monday it agreed to buy biotech company Seagen Inc (NASDAQ:SGEN) for $43 billion to bolster its cancer treatment program. The New York-based drugmaker said it would pay $229 a share in cash, a nearly 33 percent premium to Seagen’s closing price of $172.61 on Friday. Seagen is headquartered in Bothel, Washington. … Read more